Anaphylaxis inhibitory factor in IgE-dependent mast cell stimulation

Journal of Investigational Allergology and Clinical Immunology

Volumn 9, Issue 5, 1999, Pages 330-334

  Astorquiza, M I ^a   Fernandez S ^a  

^a UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

Author keywords

IgE; Inhibitory factor; Mast cell degranulation; TNF

Indexed keywords

BOVINE SERUM ALBUMIN; DINITROPHENYL ANTIBODY; IMMUNOGLOBULIN E; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANAPHYLAXIS; ANIMAL CELL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN TISSUE; IMMEDIATE TYPE HYPERSENSITIVITY; INCUBATION TIME; MAST CELL; MAST CELL DEGRANULATION; NONHUMAN; PERITONEUM MAST CELL; RAT;

ADULT; ANIMALS; CELLS, CULTURED; DINITROPHENOLS; HUMANS; IMMUNOGLOBULIN E; MAST CELLS; MICE; PASSIVE CUTANEOUS ANAPHYLAXIS; RATS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032694172     PISSN: 10189068     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Galli, S.J., Gordon, J.R., Werhil, B.K. Cytokine production by mast cell and basophils. Curr Opin Immunol 1991, 3: 865-72.
2. Wershil, B.K., Wang, Z.S., Gordon, J.R., Galli, S.J. Recruitment of neutrophils during IgE dependent cutaneous late phase responses in the mouse is mast cell dependent: Partial inhibition of the reaction with antiserum against tumor necrosis factor alpha. J Clin Invest 1991, 87: 446-53.
3. Gordon, J.R., Burd, P.R., Galli, S.J. Mast cells as a source of multifunctional cytokines. Immunol Today 1990, 11: 458-64.
4. Polosa, R. Renaissance of the effector role of the mast cell in bronchial asthma. Ann Ital Med Int 1995, 10: 126-33.
5. Astorquiza, M.I., Cisternas, C., Leal, X. Sex-dependent differences in the IgE response modulated by phytohemagglutinin. Immunol Lett 1987, 16: 27-30.
6. Astorquiza, M.I., Cisternas, C. IgE suppressor factor induced by phytohemagglutinin. Int Archs Allergy Appl Immunol 1990, 92: 223-5.
7. Astorquiza, M.I., Valdés, M. Suppression of passive cutaneous anaphylactic reaction by a human serum factor. J Invest Allergol Clin Immunol 1994, 4: 291-96.
8. Astorquiza, M.I., Calvo, M., Valdés, M. Anaphylaxis inhibitory factor: Clinical evaluation in pediatric patients. J Invest Allergol Clin Immunol 1993, 3: 92-5.
9. Ovary, Z., Caiazza, S.A., Kojima, S. PCA reacting with mouse antibodies in mice and rats. Int Arch Allergy Appl Immunol 1975, 48: 16-21.
10. Astorquiza, M.I., Droguett, M.A. An anaphylaxis inhibitory factor present in mouse serum. J Invest Allergol Clin Immunol 1996, 6: 50-4.
11. Gordon, J.R., Galil, S.J. Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature 1990, 346: 274-6.
12. Baumgartner, R.A., Deramo, V.A., Beaven, M.A. Constitutive and inducible mechanisms for synthesis and release of cytokines in immune cell lines. J Immunol 1996, 157: 4087-93.
13. Bissonnette, E.Y. Histamine inhibits tumor necrosis factor alpha release by mast cells through H2 y H3 receptors. Am J Respir Cell Mol Biol 1996, 14: 620-6.